True DiagnosticsTM

True Diagnostics (True) designs and develops innovative POC diagnostic tests and devices based on its proprietary TrueDXTM Platform, which utilizes reliable and low-cost lab methods and its own proprietary or partnered biomarkers to offer rapid diagnoses to facilitate treatment decisions in point-of-care, point-of-incidence and remote-of-care settings. The TrueDX Platforms portability and affordability allow it to be easily adopted into emerging markets to provide accurate diagnosis within minutes. For the $21 billion point-of-care market, the power of the TrueDX Platform lies in its simplicity and flexibility. Tests have an 18-month or longer shelf life with no refrigeration required. The platforms flexible...

In vitro diagnostics,point of care,assay development,and personalized medicine

True diagnosticstm operates in the Biotechnology industry.

True diagnosticstm's revenue is 11m - 100m

True diagnosticstm has 11 - 50 employees.